COVID-19 vaccination in Bangladesh

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Bangladesh COVID-19 vaccination program
Bangladesh (orthographic projection).svg
Date27 January 2021 (2021-01-27) – present
(mass vaccination started on 7 Feb 2021)[1][2]
LocationBangladesh Bangladesh
CauseCOVID-19 pandemic
TargetImmunization against COVID-19
Budget৳14,000 Crore
(US$1.68 billion)
Websitesurokkha.gov.bd

Bangladesh began administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.[1][2]

Oxford–AstraZeneca vaccine was the only COVID-19 vaccine that was authorized for emergency use from January to April 2021. Bangladesh ordered vaccine produced by Serum Institute of India, however it delivered less than half of the doses as agreed with Bangladesh government.[3] After the vaccine shortage due to this, Bangladesh approved Russian Sputnik V and Chinese BBIBP-CorV vaccines for emergency use in late April 2021.[4][5] Bangladesh has also authorized the emergency of Pfizer–BioNTech COVID-19 vaccine and to be distributed as part of COVAX. It was reported that the Bangladesh government planned to give permission to Bangladeshi made Bangavax developed by Globe Biotech Ltd.[6] to conduct the first clinical trial that got listed in the 'Draft landscape and tracker of Covid-19 candidate vaccines'[7] by the World Health Organization (WHO).[8] However fate of the Bangavax is still uncertain due to an unknown reason.[9] As of May 2021, Bangladesh has not fully approved any COVID-19 vaccine. All the four vaccines got emergency authorization only.

Background[edit]

On 21 June 2020, China invited Bangladesh to get priority access to COVID-19 vaccine once it is developed.[10] In July 2020, Sinovac Biotech was given approval by the Bangladesh Medical Research Council to begin a third-phase trial of a potential COVID-19 vaccine (now known as CoronaVac) at the International Centre for Diarrhoeal Disease Research, Bangladesh.[11] However Bangladesh later decided to cancel the trial of the vaccine after Sinovac asked to co-fund the domestic trials, which sources said would cost roughly $7 million.[12]

On 2 July 2020, A Bangladeshi private pharmaceutical company Globe Biotech Limited announced to be the first company from Bangladesh to have a COVID-19 vaccine under development.[13] The lone Bangladeshi company actually developed three COVID-19 vaccine candidates with different technologies.[14] The company named the mRNA based vaccin as Bangavax, which was initially called Bancovid.[15] Globe Biotech took all the necessary steps from December 2020 to January 2021 to get the permission for ethical approval to conduct the first clinical trial of Bangavax.[16]

On 5 November 2020, a tripartite agreement was signed between the government of Bangladesh, the Serum Institute of India, and Beximco Pharma of Bangladesh. Under the agreement Bangladesh ordered 30 million doses of Oxford–AstraZeneca vaccine from Serum through Beximco for $4 per shot.[17] The Bangladesh government paid in advance for 15 million doses.[18]

However Serum supplied only 7 million doses from the tripartite agreement in the first two months of 2021.[19] Bangladesh was supposed to receive 5 million doses per month but not received shipments in March and April.[20] As a result, rollout of vaccine has been disrupted by supply shortfalls.[20] Bangladesh then looked for alternative vaccine sources because India did not supply the vaccines.[21] Bangladesh suspended the first dosing of the Oxford-AstraZeneca vaccine from 26 April 2021 due to the supply crunch.[22]

The situation becomes complicated when the second dose of 1.3 million citizens is uncertain as India halts exports.[23] They are worried about whether they will get the second dose of Oxford–AstraZeneca vaccine on right time or whether another vaccine will be given as a second dose instead.[23][24] According to experts it would not be wise to inoculate one person with different brands.[24] Health experts and opposing political party have criticized government for turning only to India for vaccine instead of multiple sources.[25][26] In addition, several citizens of Bangladesh have expressed doubts about its effectiveness and safety.[19]

On 27 April 2021, Bangladesh's drug regulator has authorized the emergency use of Russia's Sputnik V vaccine.[4] Russia has proposed to produce their vaccine in Bangladesh with joint collaboration with a local pharmaceutical company.[21] Bangladesh has already given policy approval in this regard.[27]

On 29 April 2021, Bangladesh's drug regulator has authorized the emergency use of China's BBIBP-CorV.[5][27] Bangladesh ordered 15 million doses of Sinopharm BBIBP-CorV and received 500,000 doses as a gift.[28] Bangladesh health department has begun administering the vaccine to 1,000 medical students in the beginning to observe its effect and safety.[5][29] According to Mahbubur Rahman, DGDA Director General, “Mass inoculation will start after the observation period.”[5] It is reported that Bangladesh also wants to produce this vaccine locally. It is reported that Bangladesh interested to produce Sinovac CoronaVac COVID-19 vaccine too.[28] China has announced that they will send 600,000 doses of Sinopharm vaccine to Bangldesh as a gift.[30]

On 27 May 2021, Directorate General of Drug Administration has authorized the emergency use of Pfizer–BioNTech COVID-19 vaccine.[31] COVAX is sending 106,000 doses of Pfizer’s Covid vaccine on June 2.[32]

On 6 June 2021, DGDA has authorized the emergency use of China’s Sinovac vaccine CoronaVac.[33]

As of 11 June 2021, Bangladesh has received commitment to acquire 1 million 800 shots of AstraZeneca vaccines under the Covax programme as shared by Foreign Minister AK Abdul Momen. [34] Earlier it has been projected that there might be shortage of vaccines for some 1.5 million people who await the second dosage, due to projected shortage of AstraZeneca vaccines in Bangladesh induced by the export restrictions on the vaccine imposed by India.

On 15 June 2021, Directorate General of Drug Administration has authorized the emergency use of Johnson & Johnson COVID-19 vaccine.[35] DGHS is the local distributor of the vaccine.[36]

Vaccination program[edit]

Graph of cumulative doses administered across the country[edit]

  Total vaccination doses administered across the country    vaccinated (1st dose only)    Fully vaccinated[a]

Vaccines on order[edit]

Vaccine Approval Deployment
Oxford–AstraZeneca Green check.svg Yes Green check.svg Yes
Sputnik V Green check.svg Yes Dark Red x.svg No
Sinopharm Green check.svg Yes Green check.svg Yes [37]
Pfizer–BioNTech Green check.svg Yes Dark Red x.svg No[38]
Sinovac Green check.svg Yes Dark Red x.svg No
Janssen Green check.svg Yes Dark Red x.svg No
Globe Biotech Dark Red x.svg No No

See also[edit]

Notes[edit]

  1. ^ Recipients have received both doses

References[edit]

  1. ^ a b "Bangladesh starts COVID vaccination drive use". Al Jazeera. 28 January 2021. Retrieved 30 April 2021.
  2. ^ a b "Bangladesh starts nationwide COVID vaccination drive use". Anadolu Agency. 7 February 2021. Retrieved 30 April 2021.
  3. ^ "Covid-19: Why the crisis in vaccines? use". Prothom Alo. 29 April 2021. Retrieved 30 April 2021.
  4. ^ a b "Bangladesh approves Russia's Sputnik V COVID-19 shot; says Sinopharm pending use". REUTERS. 27 April 2021. Retrieved 30 April 2021.
  5. ^ a b c d "Bangladesh approves China's Sinopharm Covid-19 vaccine for emergency use". Dhaka Tribune. 29 April 2021. Retrieved 30 April 2021.
  6. ^ Latifee, Enamul Hafiz; Latifi, Tanzia Islam (10 May 2021). "Bangladesh should buckle up observing the record Covid-19 cases upsurge in India". The Business Standard. The Business Standard. Retrieved 15 May 2021.
  7. ^ Latifee, Enamul Hafiz; Latifi, Tanzia Islam (3 May 2021). "What Bangladesh should learn from the recent C-19 spike in India?". The Daily Observer. The Daily Observer. Retrieved 15 May 2021.
  8. ^ "'Bangavax' to get approval within a week". dailyobserver. 25 April 2021. Retrieved 30 April 2021.
  9. ^ "Bangavax first buzzed with hope, then fizzled". bdnews24. 6 May 2021. Retrieved 6 May 2021.
  10. ^ "Covid-19: Bangladesh to get priority if China develops vaccine". Dhaka Tribune. 21 January 2020. Retrieved 25 April 2021.
  11. ^ Reuters (21 July 2020). "Bangladesh to Host Late-Stage Trial of China's Sinovac COVID-19 Vaccine". The Wire. Archived from the original on 9 September 2020. Retrieved 25 July 2020.
  12. ^ "Chinese vaccine once offered to Dhaka now being used by other countries". THE BUSINESS STANDARD. 4 January 2021. Retrieved 25 April 2021.
  13. ^ "Globe Biotech's Covid-19 vaccine 'BANCOVID' listed by WHO". Daily Sun. 17 October 2020. Retrieved 30 April 2021.
  14. ^ "3 Covid-19 vaccine candidates by Bangladesh's Globe Biotech enlisted in WHO draft landscape". The Daily Star. 17 October 2020. Retrieved 30 April 2021.
  15. ^ "Globe Biotech to produce vaccine candidate for clinical trial". The Financial Express. 6 January 2021. Retrieved 30 April 2021.
  16. ^ "Globe Biotech yet to get BMRC nod for human trials". Dhaka Tribune. 22 February 2021. Retrieved 30 April 2021.
  17. ^ "Dhaka to have 330 vaccination points". The Daily Star. Retrieved 21 April 2021.
  18. ^ "Painful jabs: Bangladesh's Covid-19 immunisation fiasco". The Daily Star. 28 April 2020. Retrieved 30 April 2021.
  19. ^ a b "COVID: Bangladesh faces vaccine shortage as India halts exports". Deutsche Welle. 14 April 2021. Retrieved 21 April 2021.
  20. ^ a b "Bangladesh's Covid-19 vaccine stock to run out in one month". Dhaka Tribune. 17 April 2021. Retrieved 21 April 2021.
  21. ^ a b "Russia has proposed manufacturing its Covid-19 vaccine in Bangladesh: Momen". The Daily Star. 20 April 2021. Retrieved 21 April 2021.
  22. ^ "Nearly 2.7m receive second dose, first dose of vaccination suspended". Prothom Alo. 29 April 2020. Retrieved 30 April 2021.
  23. ^ a b "Experts Views: Can we administer different vaccine for 2nd dose?". The Daily Star. 3 May 2021. Retrieved 3 May 2021.
  24. ^ a b "Bangladesh: Uncertainty looms around COVID-19 vaccination". Anadolu Agency. 25 April 2021. Retrieved 3 May 2021.
  25. ^ "১৩ লাখ মানুষের টিকার দ্বিতীয় ডোজ অনিশ্চিত". প্রথম আলো (in Bengali). 26 April 2021. Retrieved 3 May 2021.
  26. ^ "সরকারের অযোগ্যতার কারণে বিপদগ্রস্ত গোটা জাতি". Dhaka Post (in Bengali). 26 April 2021. Retrieved 3 May 2021.
  27. ^ a b "Bangladesh OKs local production of Chinese, Russian vaccines use". Anadolu Agency. 29 April 2021. Retrieved 30 April 2021.
  28. ^ a b "Momen: Bangladesh will buy 15 million doses of Covid vaccine from China". 25 May 2021. Retrieved 28 May 2021.
  29. ^ "Bangladesh has begun administering the Chinese-produced COVID-19 vaccine to students of four medical colleges in Dhaka". bdnews24. 25 May 2021. Retrieved 29 May 2021.
  30. ^ "Covid-19 vaccine: China to send 6 lakh more Sinopharm doses to Bangladesh as gift". Daily Star. Retrieved 21 May 2021.
  31. ^ "Bangladesh drug regulator authorises Pfizer vaccine for emergency use". bdnews24.com. 27 May 2021. Retrieved 27 May 2021.
  32. ^ "Bangladesh to receive 106,000 doses of Pfizer's Covid vaccine on June 2". Dhaka Tribune. 18 May 2021. Retrieved 27 May 2021.
  33. ^ "Bangladesh approves Sinovac Covid-19 vaccine for emergency use". Dhaka Tribune. Retrieved 6 June 2021.
  34. ^ "Astrazeneca Vaccine from Covax: Bangladesh to get 1m doses 'soon'". The Daily Star. Retrieved 12 June 2021.
  35. ^ "Bangladesh approves Johnson & Johnson's Covid-19 vaccine for emergency use". Dhaka Tribune. 15 June 2021. Retrieved 15 June 2021.
  36. ^ "Single-dose Covid-19 vaccine Janssen gets emergency use authorization in Bangladesh". The Daily Star. 15 June 2021. Retrieved 15 June 2021.
  37. ^ https://dghs.gov.bd/index.php/bd/component/content/article?layout=edit&id=5649
  38. ^ "Health Minister: Covid-19 vaccination to resume from June 19". 14 June 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_in_Bangladesh&oldid=1029069032"